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Abstract
Introduction: The SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, osteomyelitis) is a
rare painful disorder, usually with a good long-term prognosis. Its etiology remains unclear, and
various treatment regimens frequently fail to control the disease.
Case presentation: A 46-year-old Caucasian female was referred for anterior chest wall and back
pain. Physical examination was unremarkable except for skin lesions noted on soles of both feet,
extremities and the face. A thoracic magnetic resonance imaging study demonstrated a lesion
characterized with bone marrow edema and proliferation of soft tissue in the sternum. A brain MRI
was requested secondary to the elevated prolactin level which was compatible with empty sella
syndrome.
Conclusion: The case presented here has the unique feature of adrenal deficiency presenting
alongside the SAPHO syndrome and is presented as the first case reported. This syndrome could
become complicated with different organ system involvement other than bone and skin. There is a
need further studies that will explore the weak relationship between SAPHO syndrome and adrenal
deficiency.
Introduction
The SAPHO syndrome (synovitis, acne, pustulosis, hyper-
ostosis, osteomyelitis) is a rare chronic painful disorder first
described by Chamot et al. in 1987 [1]. Even though it could
be encountered at any age, the most frequent presentation is
during childhood or middle age and the course is character-
ized by relapses and remissions. The most frequent and the
most problematic complaint isbonepain. Skin lesion such as
pustular psoriasis, acne, and suppurative hydraadenitis could
also be present [2,3]. The treatment is difficult and often
inadequate, despite goodprognosis, involvementofmultiple
organ systems could complicate the disease course [4]. The
SAPHO syndrome has been linked with bacteriological,
immunological, and geneticmechanisms; however, the exact
etiology still remains amystery [2,5]. The case presented here
has the unique feature of adrenal deficiency presenting
alongside the SAPHO syndrome and is presented as the first
case reported.
Case presentation
A 46-year-old Caucasian female patient from Turkey
presented with complaints of three-month old back and
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chest wall pain. The prescibed nonsteroidal antiinflam-
matory drugs (NSAID) had alleviated the symptoms;
however, skin lesions especially on the soles of the feet
erupted during the same period. The patient complained
of intermittent fatigue. Past medical history was significant
for epilepsy and four sinus surgeries. The family history
was noncontributory.
Physical examination was unremarkable except for skin
lesions noted on soles of both feet, extremities and the
face. The lesions were interpreted as pustular psoriasis by
dermatology (Figure 1).
Laboratory investigation obtained for differential diagno-
sis included complete blood count, routine biochemistry,
24-hour urine for protein, protein and immunoglobulin
electrophoresis, Rheumatoid factor, anti-nuclear anti-
bodies, anti-DNA, complements, immunoglobulins,
tumor markers, hepatitis serologies, group agglutinations
tests and were all within normal limits. There was no
Bence-Jones proteinuria and the patient was HLAB27
negative. Among the hormone tests (FSH, LH, DHEAS,
estradiol, progesteron, insulin) requested, prolactin levels
were found to be elevated (50.48 ng/ml, normal range:
4.8-23.3). ACTH basale level was <10 (normal range:
10-46) and cortisol level was 11.26 (normal range: 5-
25 µg/dl). Cortisol response to insulin was normal. A
throat culture obtained secondary to postnazal discharge
only revealed normal flora. The cultures of the bacter-
iological specimes obtained from the plantar lesions
remained without growth. The chest X-ray was normal.
An abdominal ultrasound demonstrated grade 2 hepatos-
teatosis. A bone densitometry revealed osteopenia of
the hip.
Cervical X-rays demonstrated only straightening of the
cervical lordosis and nonspecific degenerative changes.
A lumbosacral X-ray obtained showed degenerative
changes of the facets. The sacroiliac, feet and heel graphies
were all within normal limits. Bone scan revealed focal
area of increased activity in mid-sternal region. A thoracic
magnetic resonance imaging (MRI) study demonstrated a
lesion characterized with bone marrow edema and
proliferation of soft tissue in the upper 1/3 of the sternum.
Clinical and radiological findings led to the diagnosis of
the SAPHO syndrome. A brain MRI was requested
secondary to the elevated prolactin level which was
compatible with empty sella syndrome with bowl-like
widening of the sella, decreased gland height and spread
inside the sella. The patient was additionally diagnosed
with “adrenal deficiency” under stress. The patient was
prescribed difluortolone 2 valerate- chlorquinaldole
10 mg creme for skin lesions and a NSAID (Diclofenac
75 mg BID) for pain. Despite improvement of pain
control, the skin lesions continued to demonstrate waxing-
and-waning course (Figure 1). For adrenal deficiency, the
patient was started on hyrocortisone 15 mg p.o. daily and
Prednol 20 mg IV p.r.n. as stress dose. ACTH and cortisol
levels were to be monitored at monthly intervals.
After six months, the patient had less chest wall pain with
NSAID. The skin lesions continued to demonstrate
waxing-and-waning course. There are no signs or labora-
tory values of suspected systemic involvement.
Discussion
An example of the rarely occuring SAPHO syndrome, with
early diagnosis and the first reported concomitant
occurance of adrenal deficiency is presented here.
Several bacteriological, immunological, and genetic
mechanisms have been proposed as the etiology and
thought to be involved in the pathogenesis of the SAPHO
syndrome; however, to this day, the exact etiology remains
unclear [4,5]. The most frequently recovered pathogen
from the bone lesions seen in this syndrome is Propione-
baterium acnes; however, in many cases as in ours the
pathogenic organism can never be identified [6]. There
are ongoing debates regarding possible links toHLA profile
and ankylosing spondylitis in the etiology. While thirteen
percent of all the patients are found to beHLAB27 positive,
most patients are negative as in the case presented here [7].
However, some authors maintain that the SAPHO syn-
drome can be regarded as a seronegative spondyloarthro-
pathy due to the presence of high incidence of sacroiliitis,
enthesopathy, axial involvement, inflammatory bowel
disease and HLAB27 carriage and the absence of rheuma-
toid factor [6]. Maugars et al. have reported that 7 patients
out of 21 have met the European classification criteria for
spondyloarthropathy [8]. However, our patient does not
Figure 1. Skin lesions were seen on soles of both feet.
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have findings compatible with seronegative spondyloar-
thropathy. Even though there is no validated diagnostic
criteria, a patient has to fulfill at least one criterion
described by Benhamou et al. [9] for diagnosis (i). severe
acne accompanying joint lesions (ii). severe palmoplantar
pustulosis and joint involvement (iii). osteohypertrophy of
the sternoclavicular joint, spine or the extremities (iv).
chronic recurrent multiple osteomyelitis. In the absence of
skin lesions, the last two criteria could be adequate for
diagnosis. However, this investigator has been criticized for
not including bone lesions in the diagnostic criteria [5].
According to records of 120 patientswith long-term follow-
up, 84% of the patients present with skin lesions similar to
our patient [10].While the chest wall is frequently involved
in this syndrome (clavicula, sternum, sternoclavicular
joint), involvement of spine, ribs, tarsal region,mandibula,
and long bones have also been reported [10,11]. The most
prevalent complaint in the majority of cases is chest pain
[12]. Our patient did not have complaints other than back
and chest wall pain and skin lesions.With these complaints
and the presence of pustular psoriasis and sternal involve-
ment, the patient was thought to meet the diagnostic
criteria for the SAPHO syndrome.
Laboratory results are nonspecific in the SAPHO syndrome
and the requested work-up is important for differential
diagnosis [3,11]. Our patient did not have any abnormal
laboratory findings except the eleveated prolactin level.
The role of prolactin in the interrelation between the
endocrine system and the immune system has a biphasic
character. Generally lesswell known is that prolactin may
also play a role in the activity of autoimmune diseases
such as systemic lupus erythematosus and rheumatoid
arthritis. Further studies should be carried out on this
subject to understand the exact mechanism. The hormonal
tests obtained were helpful in the diagnosis of adrenal
deficiency which might have gone unrecognized
otherwise.
Physical examination and clinical assessment are impor-
tant for reaching the right diagnosis. In patients who only
have atypical findings, a bone biopsy taken from the
inflamed bones could become necessary for definitive
diagnosis [5,6,11].
The radiological findings in the SAPHO syndrome, while
reported on quite extensively, are nonspecific [13]. The
most prominent feature is the presence of hyperosteosis
and osteitis. Bone scan findings are nonspecific and bone
scan should be performed in the asymptomatic phase or
when direct radiological examinations are normal [3].
Computerized tomography (CT) could clearly show
hyperostotic and lytic lesion and magnetic resonance
imaging (MRI) can be used in the definitive localization of
active inflammatory changes [6,13]. MRI is important in
the follow-up of the disease and is quite sensitive. In our
patient, other than sternal involvement, there was no bone
involvement found in the imaging studies.
Different disease groups should be entertained in the
differential diagnosis of the SAPHO syndrome. The radio-
graphical changes in the long bones could be confusedwith
infectious osteomyelitis and bone tumors (such as Ewing
sarcoma). In cases with severe multiple destructive lesions,
metastatic bone involvement must be ruled out. There is
also reports of autoimmune disease such as rheumatoid
arthritis presenting simultaneously with the SAPHO
syndrome [3].
Treatment is not necessary in the SAPHO syndrome.
NSAIDs recommended for pain are effective and used
frequently [3,14]. Our patient had significant pain relief
after symptomatic treatment with NSAIDs. In cases
with prominent bone involvement, steroids, colchicin,
doxycyclin, salazopyrine, interferone and bisphosphonates
have been reported to be effective [3]. The anti-osteoclastic
and antiinflammatory effects of bisphosphonates are
beneficial in treatment [2]. The early use of bispho-
sphonates in the early stages of the disease has been
reported to be beneficial for the management of the bone
lesions, however, caution must be exerted regarding the
adverse effects of themedication onkidneys and the quality
of the bone [6]. In cases with more prominent skin lesions
rather than bone involvement and when the pathogenic
organism can be identified, antibiotics are preferred over
biphosphonate treatment secondary to lower cost and
widespread availibility [6]. Positive experiences with anti-
TNF agents are also reported. However, these medications,
despite being effective on osteoarticular complaints, could
lead to exacerbation of the skin lesions [14]. The steroids
added to the therapeutic regimen of NSAIDs for the
treatment of the adrenal insufficency in our patient are
thought to potentially be effective on the bone lesions
as well.
Conclusion
The case presented herein is the first reported case of the
quite rare SAPHO syndrome with adrenal deficiency. We
have no hypothesis to better understand this association.
There is a need further studies that will explore the weak
relationship between SAPHO syndrome and adrenal
deficiency. This syndrome could become complicated
with different organ system involvement other than bone
and skin.We believe that systematic evaluationwith review
of all organ systems during work-up would be beneficial in
determining early diagnostic and therapeutic strategies.
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